Shares of Aveanna Healthcare Holdings Inc. (AVAH) surged 9.96% in pre-market trading on Thursday following the company's announcement of better-than-expected first-quarter results and an upward revision to its full-year 2025 guidance.
The home healthcare provider reported Q1 revenue of $559.2 million, significantly beating the analyst estimate of $513.1 million. Adjusted EBITDA came in at $67.4 million, also surpassing expectations of $39.9 million. The company's net income for the quarter stood at $5.2 million, translating to earnings per share of $0.03.
In light of the strong performance, Aveanna raised its full-year 2025 outlook. The company now expects revenue to exceed $2.15 billion, up from the previous guidance range of $2.10 - $2.12 billion. Additionally, the adjusted EBITDA guidance was increased to over $207 million, a substantial boost from the earlier projected range of $190 - $194 million. This positive revision in outlook appears to be a key driver behind the stock's pre-market rally, as investors react favorably to the improved financial prospects for the company.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。